Eagle Bancorp (NASDAQ:EGBN) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.16 by 13.79 percent. This is a 1.54 percent increase over earnings of $1.30 per share from the same period last year. The company reported quarterly sales of $85.60 million which beat the analyst consensus estimate of $84.20 million by 1.66 percent. This is a 9.48 percent increase over sales of $78.19 million the same period last year.
Milestone Pharmaceuticals Announced Saturday: Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR Showed Statistically Significant Reduction In Ventricular Rate By 30 Beats Per Minute For Episodes Of Atrial Fibrillation With Rapid Ventricular Ra…
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced positive Phase 2 data that show etripamil nasal spray resulted in rapid and statistically superior ventricular rate reduction and improved symptom-relief in
